Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know
Update: 2025-11-03
Description
Kimberly-Clark's $49 billion acquisition of Kenvue, makers of Tylenol, sends shockwaves through the consumer products industry. The deal, valued at nearly $50 billion, sees Kenvue shareholders receive $3.50 in cash and a slice of Kimberly-Clark stock for each share owned. The merger comes as both companies face challenges, including changing prices, international trade rules, and legal issues. The acquisition could reshape the industry and set a new course for brands found in homes across the country.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
